skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: A bivalent Epstein-Barr virus vaccine induces neutralizing antibodies that block infection and confe

Journal Article · · Sci. Transl. Med.

Research Organization:
Argonne National Laboratory (ANL), Argonne, IL (United States). Advanced Photon Source (APS)
Sponsoring Organization:
DOE - Office Of Science
OSTI ID:
1873534
Journal Information:
Sci. Transl. Med., Vol. 14
Country of Publication:
United States
Language:
ENGLISH

References (44)

The need and challenges for development of an Epstein-Barr virus vaccine journal April 2013
Epstein-Barr Virus: An Important Vaccine Target for Cancer Prevention journal November 2011
Post-Transplantation Lymphoproliferative Disorders in Adults journal February 2018
Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis journal January 2022
Clonally expanded B cells in multiple sclerosis bind EBV EBNA1 and GlialCAM journal January 2022
Epstein–barr virus vaccines journal January 2015
Epstein-Barr virus receptor of human B lymphocytes is the C3d receptor CR2. journal July 1984
The extracellular domain of the Epstein-Barr virus BZLF2 protein binds the HLA-DR beta chain and inhibits antigen presentation journal August 1996
Ephrin receptor A2 is a functional entry receptor for Epstein–Barr virus journal January 2018
Recombinant gp350 Vaccine for Infectious Mononucleosis: A Phase 2, Randomized, Double‐Blind, Placebo‐Controlled Trial to Evaluate the Safety, Immunogenicity, and Efficacy of an Epstein‐Barr Virus Vaccine in Healthy Young Adults
  • Sokal, Etienne M.; Hoppenbrouwers, Karel; Vandermeulen, Corinne
  • The Journal of Infectious Diseases, Vol. 196, Issue 12 https://doi.org/10.1086/523813
journal December 2007
Protection of cottontop tamarins against Epstein–Barr virus-induced malignant lymphoma by a prototype subunit vaccine journal November 1985
Soluble Rhesus Lymphocryptovirus gp350 Protects against Infection and Reduces Viral Loads in Animals that Become Infected with Virus after Challenge journal October 2011
Rabbits immunized with Epstein-Barr virus gH/gL or gB recombinant proteins elicit higher serum virus neutralizing activity than gp350 journal July 2016
Rational Design of an Epstein-Barr Virus Vaccine Targeting the Receptor-Binding Site journal August 2015
Immunization with Components of the Viral Fusion Apparatus Elicits Antibodies That Neutralize Epstein-Barr Virus in B Cells and Epithelial Cells journal May 2019
Assessment of squalene adjuvanted and non-adjuvanted vaccines against pandemic H1N1 influenza in children 6 months to 17 years of age journal September 2012
Modeling EBV infection and pathogenesis in new-generation humanized mice journal January 2015
Humanized Mouse Models of Epstein-Barr Virus Infection and Associated Diseases journal March 2013
Experimental Infection of NOD/SCID Mice Reconstituted with Human CD34 + Cells with Epstein-Barr Virus journal December 2004
A New Humanized Mouse Model of Epstein‐Barr Virus Infection That Reproduces Persistent Infection, Lymphoproliferative Disorder, and Cell‐Mediated and Humoral Immune Responses journal September 2008
A Pentavalent Epstein-Barr Virus-Like Particle Vaccine Elicits High Titers of Neutralizing Antibodies against Epstein-Barr Virus Infection in Immunized Rabbits journal April 2020
Immunization of common marmosets with Epstein‐Barr virus (EBV) envelope glycoprotein gp340: Effect on viral shedding following EBV challenge journal August 1998
Healthy rabbits are susceptible to Epstein-Barr virus infection and infected cells proliferate in immunosuppressed animals journal February 2015
Immune Control and Vaccination against the Epstein–Barr Virus in Humanized Mice journal December 2019
Passive Transfer of Immune Sera Induced by a Zika Virus-Like Particle Vaccine Protects AG129 Mice Against Lethal Zika Virus Challenge journal January 2018
H5N1 Whole-Virus Vaccine Induces Neutralizing Antibodies in Humans Which Are Protective in a Mouse Passive Transfer Model journal August 2011
Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model journal June 2020
Design of a broadly reactive Lyme disease vaccine journal May 2020
Neutralizing Antibodies Protect against Oral Transmission of Lymphocryptovirus journal June 2020
A potent and protective human neutralizing antibody targeting a novel vulnerable site of Epstein-Barr virus journal November 2021
Elicitation of Broadly Neutralizing Influenza Antibodies in Animals with Previous Influenza Exposure journal August 2012
Integration, scaling, space-group assignment and post-refinement journal January 2010
XDS journal January 2010
Solving structures of protein complexes by molecular replacement with Phaser journal December 2006
Phaser crystallographic software journal July 2007
Features and development of Coot journal March 2010
PHENIX: a comprehensive Python-based system for macromolecular structure solution journal January 2010
Epstein–Barr virus infection and replication in a human epithelial cell system journal March 1992
High Levels of Antibody that Neutralize B-cell Infection of Epstein–Barr Virus and that Bind EBV gp350 Are Associated with a Lower Risk of Nasopharyngeal Carcinoma journal July 2016
Human antibody titers to Epstein–Barr Virus (EBV) gp350 correlate with neutralization of infectivity better than antibody titers to EBV gp42 using a rapid flow cytometry-based EBV neutralization assay journal September 2009
Passive Transfer of Antibodies Protects Immunocompetent and Immunodeficient Mice against Lethal Ebola Virus Infection without Complete Inhibition of Viral Replication journal May 2001
Increasing the breadth and potency of response to the seasonal influenza virus vaccine by immune complex immunization journal September 2017
Priming of protective T cell responses against virus-induced tumors in mice with human immune system components journal June 2009
UCSF Chimera?A visualization system for exploratory research and analysis journal January 2004